METHOD FOR ASSAY OF MICROORGANISM WITH REDUCED ADAPTATION TO SPECIFIC ENVIRONMENT, DNA (VARIANTS), VIRULENCE GENE, POLYPEPTIDE, METHOD FOR ASSAY OF COMPOUND, ANTISENSE NUCLEIC ACID, METHOD FOR HOST TREATMENT AND PHARMACEUTICAL COMPOSITION Russian patent published in 2004 - IPC

Abstract RU 2241758 C2

FIELD: molecular biology, genetic engineering, medicine, pharmacy.

SUBSTANCE: invention relates, in particular, to a method for identifying genes taking part in adaptation of body to the environment of its residence. Invention proposes a method for identifying a microorganism with reduced adaptation to the specific environment. Method involves preparing multiple microorganisms each of that is mutated independently by insertion inactivation of nucleic acid gene comprising the unique marker sequence so each mutant comprises different marker sequences, or clones of indicated microorganism, stage (1). Individual storage of each mutant sample prepared at the stage (1) and individually accumulated nucleic acid comprising the unique marker sequence from each individual mutant, stage (2). Addition of multiple mutants at the stage (1) to indicated specific environment and providing to these microorganisms that able to this the possibility to growth in indicated environment medium, stage (3). Isolation of microorganisms from indicated environment or its selected part and isolation of nucleic acid from these microorganisms, stage (4). Comparison of marker sequences in nucleic acid isolated at the stage (4) with the unique marker sequence of each individual mutant accumulated at the stage (2), stage (5). Selection of the individual mutant that doesn't comprise any of marker sequences isolated at the stage (4), stage (6). Also, invention proposes DNA (variants) responsible for reducing adaptation of microorganism to environment isolated from genome Salmonella, the virulence gene comprising this DNA, and polypeptide encoded by this gene. Except for, invention proposes a method for assay of compound reducing adaptation of microorganism to environment. The proposed method involves selection of such compound that inhibits the function of gene comprising DNA responsible for reducing adaptation of microorganism to environment. Also, invention proposes an anti-sense nucleic acid obtained by above indicated method. The proposed anti-sense nucleic acid is used in method for treatment of host infected or sensitive to infection with microorganism, and it is a component of pharmaceutical composition inhibiting the pathogenic microorganism.

EFFECT: improved assay and treatment method, valuable biological and medicinal properties of gene, nucleic acid and composition.

60 cl, 17 dwg, 1 tbl, 8 ex

Similar patents RU2241758C2

Title Year Author Number
METHOD OF PREPARING AN ATTENUATED STRAIN OF BACTERIUM SALMONELLA 1988
  • Gordon Dougan
  • Stiven Nevil Chehtfild
  • Karlos Khormeche
RU2114172C1
METHOD OF PREPARING AN ATTENUATED STRAIN OF BACTERIUM SALMONELLA AND A VACCINE 1992
  • Jan Dzhordzh Charl'Z
  • Stiven Neville Chehtfild
  • Nejl Frehzer Fejrveter
RU2126447C1
LIVE ATTENUATED VACCINES 2010
  • Brauning, Glenn Frehnsis
  • Markkhehm, Fillip Frehnsis
  • Tseng, Chi-Ven
RU2556813C2
PEPTIDE WITH NEISSERIA MENINGITIDIS ANTIGENE ACTIVITY, POLYNUCLEOTIDE ENCODING THE SAME, VACCINE FOR PREVENTION AND TREATMENT OF DISEASES AND CONDITIONS INDUCED BY NEISSERIA MENINGITIDIS, (VARIANTS), ANTIBODY COUPLING WITH SAID PEPTIDE 2001
  • Tang Kristof
RU2252224C2
LIVE ATTENUATED Pasteurella multocida BACTERIUM, BASED VACCINE, METHOD FOR MAKING VACCINE AND USING SUCH BACTERIUM FOR MAKING VACCINE FOR ANIMAL OR HUMAN PROTECTION 2005
  • Lo Jujgan
  • Vermehj Paul'
  • Jakobs Antonius Arnol'Dus Kristian
RU2415926C2
GENE AND PROTEIN OF VIRULENCE AND THEIR USING 2000
  • Klark Ehnda Ehlizabet
  • Zkhou Likuing
  • Shia Zhaklin Ehlizabet
  • Feldman Robert Grehkhehm
  • Kholden Dehvid Vill'Jam
RU2240327C2
ANTIPLAGUE VACCINE 1996
  • Titboll Richard Uill'Jam
  • Uill'Jamson Ehtel' Dajehn
  • Liehri Sofi Ehmma Klehr
  • Ojston Petra Klehr Fark'Jukhar
  • Bennett Ehlis Mari
RU2197988C2
MUTANT MYCOPLASMA HYOPNEUMONIAE STRAINS 2013
  • Gonsales Gonsales Luis
  • Pinol Ribas Khaume
  • Montane Khiralt Khordi
  • Kamats Malet Mariya
  • Kerol Murilo Enrike
  • Sitkha Arnau Marta
RU2689671C2
ANALOGUE HIN47 OF HAEMOPHILUS WITH REDUCED PROTEASE ACTIVITY 1995
  • Luzmor Shina M.
  • Jang Jan-Ping
  • Chong Pele
  • Oomen Rejmond P.
  • Kljajn Mishel' Kh.
RU2196176C2
VACCINE CAPABLE TO MAKE IMMUNITY IN HOST AGAINST INFECTION CAUSED BY STREPTOCOCCUS GROUP B, METHOD OF PREVENTION OF INFECTION CAUSED BY STREPTOCOCCUS GROUP B AND A METHOD OF ATTENUATION OF INFECTION CAUSED BY STREPTOCOCCUS GROUP B 1990
  • Dzhejms L.Majkl
  • Dennis L.Kehsper
  • Frederik M.Os'Jubel
RU2113234C1

RU 2 241 758 C2

Authors

Kholden Dehvid Uil'Jam

Shia Zhaklin Ehlizabet

Khenzel' Mikhaehl'

Dates

2004-12-10Published

1995-12-11Filed